Key result
IV magnesium sulfate shows ~5-fold greater antiarrhythmic effect in low versus normal ionized magnesium patients.
Why the study?
No method previously existed to measure physiologically active free ionized magnesium in blood to guide antiarrhythmic treatment in critically ill patients with arrhythmias.
Does intravenous magnesium sulfate improve antiarrhythmic effects in critically ill patients with cardiac arrhythmias and low serum ionized magnesium compared to those with normal levels?
Comparison
Intravenous magnesium sulfate in patients with low iMg2+ vs normal iMg2+
Design
Observational cohort study
Follow-up
Acute
Authors
Loading...
May support selective IV magnesium use in low-iMg2+ arrhythmia patients; hypothesis-generating and requires randomized confirmation before practice change.
Does intravenous magnesium sulfate improve antiarrhythmic effects in critically ill patients with cardiac arrhythmias and low serum ionized magnesium compared to those with normal levels?
Absolute Event Rate: 88% vs 17%
p-value: p=< 0.05
Intravenous magnesium sulfate is highly effective for the acute management of cardiac arrhythmias in critically ill patients specifically when serum ionized magnesium levels are low.
Kasaoka et al. (1996) studied Cardiac arrhythmias in critically ill patients (n=14). Intravenous magnesium sulfate vs. Patients with normal iMg2+ level (>0.40 mmol/L) unresponsive to conventional antiarrhythmic drugs was evaluated on Antiarrhythmic effect (p=< 0.05). Intravenous magnesium sulfate had an antiarrhythmic effect in 88% of critically ill patients with low ionized magnesium compared to 17% of those with normal levels (p < 0.05).
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: